IZRL - ETF AI Analysis
Top Page
ARK Israel Innovative Technology ETF (IZRL)
Rating:53Neutral
Price Target:―
Positive Factors
Strong Standout Holdings
A few of the top positions, such as Compugen and Camtek, have shown very strong recent performance, helping support the fund’s returns.
Innovative Tech and Health Focus
The ETF is heavily invested in technology and health care companies, giving investors targeted exposure to innovative, growth-oriented businesses.
Balanced U.S. and Israel Exposure
Holdings are split mainly between the U.S. and Israel, providing a mix of domestic and international companies tied to Israel’s innovation theme.
Negative Factors
Mixed Performance So Far This Year
The fund’s year-to-date return is slightly negative, showing that recent gains have not fully offset earlier weakness.
High Fee for a Thematic ETF
The expense ratio is relatively high compared with many broad-market ETFs, which can eat into long-term returns.
Concentrated in Risky Growth Sectors
Heavy exposure to technology and health care, along with several top holdings that have recently lagged, can make the ETF more volatile and sensitive to market downturns.
IZRL vs. SPDR S&P 500 ETF (SPY)
AUM141.70M
RegionMiddle East & Africa
Expense Ratio0.49%
Beta0.91
IssuerARK
Inception DateDec 05, 2017
Dividend Yield2.59%
Asset ClassEquity
Index TrackedARK Israeli Innovation (USD)(TR)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,509
30 Day Avg. Volume12,968
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IZRL Summary
IZRL is the ARK Israel Innovative Technology ETF, which follows the ARK Israeli Innovation index and focuses on Israeli tech-driven companies. It holds businesses involved in areas like cybersecurity, software, biotech, and digital services. Well-known names in the fund include website platform Wix and software company JFrog. Someone might invest in IZRL to get diversified exposure to Israel’s fast-growing technology scene in a single investment, with the potential for long-term growth. A key risk is that it is heavily focused on technology and Israel, so its price can swing a lot and may drop sharply if tech or the region struggles.
How much will it cost me?The ARK Israel Innovative Technology ETF (IZRL) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 you invest. This expense ratio is slightly higher than average because the fund is actively managed and focuses on a specific niche, requiring more research and management effort.
What would affect this ETF?The ARK Israel Innovative Technology ETF (IZRL) could benefit from global demand for advanced technologies like artificial intelligence and cybersecurity, areas where Israeli companies excel. However, geopolitical tensions in the Middle East or regulatory changes affecting tech companies could pose risks to its performance. Economic conditions, such as interest rate hikes, may also impact growth-focused sectors like technology.
IZRL Top 10 Holdings
IZRL is essentially a bet on Israel’s innovation engine, with a heavy tilt toward tech and health-care names. Software player JFrog has been rising sharply and looks like one of the fund’s key performance drivers, while Radware and Radcom add steady strength from the cybersecurity and network space. On the health side, Brainsway and Sol-Gel are climbing, helping offset more mixed, higher-risk stories like Alpha Tau Medical. Mobileye, a big name in autonomous driving, has been lagging, slightly dragging on returns. Overall, it’s a concentrated, Israel-first tech and biotech story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alpha Tau Medical Ltd | 1.78% | $2.50M | $1.19B | 352.01% | 38 Underperform | |
| Silicom | 1.74% | $2.44M | $251.41M | 181.56% | 57 Neutral | |
| Sol-Gel Technologies | 1.68% | $2.36M | $271.98M | 851.31% | 51 Neutral | |
| Brainsway | 1.65% | $2.31M | $608.90M | 172.95% | 77 Outperform | |
| Mobileye Global, Inc. Class A | 1.60% | $2.25M | $7.76B | -44.20% | 44 Neutral | |
| Riskified | 1.59% | $2.23M | $699.79M | -6.43% | 51 Neutral | |
| JFrog | 1.59% | $2.23M | $10.72B | 115.57% | 73 Outperform | |
| Radcom | 1.58% | $2.22M | $232.50M | -1.02% | 76 Outperform | |
| Check Point | 1.57% | $2.21M | $14.29B | -39.04% | 76 Outperform | |
| Radware | 1.57% | $2.21M | $1.31B | 2.11% | 65 Neutral |
IZRL Technical Analysis
Negative
―
Price Trends
30.48
Negative
29.64
Positive
29.38
Positive
Market Momentum
>-0.01
Positive
45.63
Neutral
47.68
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IZRL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 30.28, equal to the 50-day MA of 30.48, and equal to the 200-day MA of 29.38, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.63 is Neutral, neither overbought nor oversold. The STOCH value of 47.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IZRL.
IZRL Peer Comparison
Comparison Results
Performance Comparison
IZRL
ARK Israel Innovative Technology ETF
29.89
1.67
5.92%
TECB
iShares U.S. Tech Breakthrough Multisector ETF
―
―
―
FDTX
Fidelity Disruptive Technology ETF
―
―
―
LOUP
Innovator Loup Frontier Tech ETF
―
―
―
BCTK
Baron Technology ETF
―
―
―
ITEQ
BlueStar Israel Technology ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents